IL3RA and neoplasm: Moreover, a slight, but not significant reduction of PAS-positive/CD31-negative vessels, corresponding to the vascular network built by tumor cells (VM), was observed upon anti-IL-3R-EV treatment (Supplementary Fig. S5).